The concept of field cancerisation, first proposed by Slaughter et al. in 1953 , has frequently been quoted to explain the occurrence of multiple primary cancers in the head and neck region and recurrence following complete excision of the original tumour. The adverse influence that these second malignant tumours (SMT's) may have on such patients has been reviewed elsewhere (Ogden, 1991) . Virtually all reports concerned with SMT's attribute this to the effect of alcohol and tobacco (Strong et al., 1984; Lippman & Hong, 1989) . Interestingly when Slaughter et al. (1953) published their hypothesis they were not aware of any particular aetiological factor for oral cancer. However it should not be forgotten that SMT's can also occur in those who have never smoked or taken alcohol, as well as in those who gave up both habits after diagnosis of the initial tumour (Wynder et al., 1969 Incze et al. (1982) found evidence at an ultrastructural level for premalignancy in normal oral mucosa remote from head and neck tumours. Namely an increase in nuclear area and altered nuclear to cytoplasmic area ratio. Despite both groups of patients smoking, they concluded that the changes observed were probably related to tobacco use. However, no account was taken of alcohol intake, a frequent co-factor in such patients. Furthermore, examination of nuclear and cytoplasmic area is more reliable by light microscopy than electron microscopy.
More recent evidence for field change has come from studies utilising exfoliative cytology. We have reported a reduction in cytoplasmic area (CA) for normal buccal mucosa in patients with malignant disease both distant from and within the oral cavity, compared with cancer free patients . That this was indeed significant derives from the fact that other factors that could have influenced such results, e.g., anaemia, inflammation and radiotherapy were excluded. Furthermore, this reduction in CA (which mirrors that seen in smears and biopsies (Wright & Shear, 1985) from lesions that later become malignant) occurred irrespective of the use of either alcohol or tobacco . However, such 'field change' did not result in aberrant DNA profiles Much attention has recently focused upon the keratin cytoskeleton (Cooper et al., 1985; Lane & Alexander, 1990) (Makin et al., 1984) but its major specificity is for K8, with some K7 reactivity (Smedts et al., 1990) . Normal goat serum acted as the negative control and LP34 the positive control (since it identifies a set of keratins that are represented in all epithelial cells).
A standard protocol was followed, using the avidin biotin complex technique (Vectastain, Vector Labs, Peterborough, England). Briefly, following incubation with the primary antibody, the sections were rinsed in PBS and then the link antibody (biotinylated anti-mouse immunoglobin -BAMG) applied for 30 min, at room temperature. The sections were then rinsed with PBS prior to applying the avidin-biotin complex. This consists of avidin together with biotinylated horseradish peroxidase which is allowed to complex for 30 min prior to its application to the tissue section for 30 min, at room temperature. Sections were once again rinsed with PBS prior to addition of the substrate for the horseradish peroxidase enzyme. This consisted of diaminobenzidine tetrahydrochloride (DAB, 5 mg in 10 ml PBS) freshly filtered and mixed with hydrogen peroxide (5 ml of 30 vols) which was applied for 5 to 10 min at room temperature. Sections were again washed in PBS prior to the application of a counterstain (namely immersion in Mayers haematoxylin for 15 to 30 s) and then washing in Scott's tap water substitute. The corresponding tumours were treated in a similar manner for keratin expression.
Results
Examination of H & E stained sections revealed that the morphology of most biopsies was within the limits of normal variation in normal mucosa. Occasionally mild basal cell hyperplasia and acanthosis were observed. All were considered free of tumour.
Keratin cytoskeleton 'Normal' oral mucosa was obtained from 34 patients with oral cancer and 20 patients with no history of oral cancer and no obvious oral mucosal abnormality. Table I describes the extent of expression of each keratin studied in terms of basal (B) cell and suprabasal (S) cell expression. In addition smoking and alcohol habits are detailed (where known).
The following keratin profiles were confirmed in normal oral mucosa from non cancer patients (Table II Figure 1) . The associated tumours except one were also positive to CAM 5.2. This extent of CAM 5.2 positivity never occurred in the non cancer patients except for the occasional Merkel cell (Table 1) .
Keratin 19 was expressed throughout the suprabasal epithelium in 'non-keratinising' sites in five of 28 biopsies (e.g. Figure 2 ) and was also frequently identified in the basal cells of 'keratinising' sites in 'normal' mucosa from oral cancer patients. Although the former was not seen in non cancer patients, the latter was occasionally observed. (Four of the five with suprabasal K19 expression also had K19 positive tumours). Basal cell expression of K19 was lost in six cases (Figure 3a) even when the tumours expressed K19 (Figure 3b) .
Keratin 13 was identified in all but two of 18 biopsies from 'normal' floor of mouth. In contrast K13 was expressed throughout the suprabasal cells of these 'non-cornifying' sites in non cancer patients.
Keratin 10 was expressed throughout the suprabasal region in one of ten cases from normal buccal mucosa and two of 18 cases from normal floor of mouth (e.g. Figures 4, 5) . It is of interest that in the former the corresponding tumour was K1O positive but not in the latter case.
The pan-epithelial marker LP34 stained all the epithelial cells. Table III (Morgan et al., 1987; Sawef et al., 1991) although occasional staining of Merkel cells in the basal region has been observed (Morgan et al., 1987 (Clausen et al., 1986) (Morgan et al., 1987a) . We have also found such expression in a significant number of well differentiated tumours (Ogden et al., 1993) . In so doing such basal cell expression mirrors that seen in the corresponding tumours (Morgan et al., 1987a; Ogden et al., 1993) .
Further evidence supportive of a field change derives from the suprabasal expression of K19 in 'normal' buccal mucosa and floor of mouth region. Significantly such changes occurred in those sites most frequently affected by oral cancer (Mashberg & Samit, 1989) . In most cases the corresponding tumours were also positive. It has been suggested that K19 expression, particularly in those oral sites where it is not usually seen, is related to inflammation (Bosch et al., 1989 ). However we would challenge this since there was little evidence in most of our cases for profound inflammatory change. An increase in K19 expression within oral leukoplakias has been associated with mucosal instability and malignant change (Lindberg & Rheinwald, 1989) . Since increased expression of K19 was not seen in the non cancer patients such a profile may herald a propensity tc undergo malignant change. However, loss of basal cell expression of throughout the suprabasal epithelium of 'normal' floor of mouth (x 160). K19 in 'non-keratinising' sites was also identified, even in the mucosa above a K19 positive tumour (Figure 3c ). Thus the significance of K19 expression (or lack of it) appears unclear. Table I the tobacco and alcohol habits are recorded where known. Given that other important tumour diagnostic markers such as p53 can be influenced by smoking habits Field et al., 1992) , the influence of tobacco on cytokeratin expression could be significant. For example, although there were approximately equal numbers of cases that were negative for CAM 5.2 in smokers compared to non-smokers, basal cell staining was much more frequent in the smoking group. There was no obvious association of tobacco or alchohol use with the other keratins studied. Furthermore, altered keratin profiles were also seen in those who did not smoke or take alcohol. Since further tumours can arise even in those abstaining from these high risk aetiological factors, the keratin profiles obtained offer a sensitive indication of altered tissue differentiation.
Whether these cases of inappropriate keratin expression are indicative of an increased likelihood of further tumours is not known, since this study only covers a 3 year period.
The changes in keratin expression reported above should not however be interepreted as inadequate excision of the primary lesion until their clinical significance is known. According to a recent review (Shaha et al., 1988 ) multiple primary tumours occur in approximately 10% of all head and neck cancer patients, thus a clinically significant field change may not always occur.
Classical histopathological diagnosis relies upon the assessment of H & E stained sections to check that the margins are clear of tumour. The significance of these reported changes in keratin expression in essentially normal oral mucosa of oral cancer patients now requires evaluation. They may yet become a valuable additional test in the diagnostic and prognostic evaluation of patients with oral carcinomas.
